Purification of recombinant Vaccinia virus for oncolytic and immunotherapeutic applications using monolithic column technology
Vaccinia virus Lister strain, a large, structurally complex double stranded DNA pox virus, is being developed by a number of organisations around the world as an oncolytic and immunotherapeutic agent for the treatment of a broad range of cancers. Should these therapies prove to be efficacious in the...
Main Author: | Vincent, David Isaac William |
---|---|
Published: |
University College London (University of London)
2017
|
Subjects: | |
Online Access: | https://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.747038 |
Similar Items
-
Monolith absorbants as a capture step for virus-like particles
by: Burden, C. S.
Published: (2013) -
High cell density purification strategies for application to antibody and virus-vectored biopharmaceutical products
by: De Villiers, Ann-Marie
Published: (2018) -
Lipid foulant interactions during the chromatographic purification of virus-like particles from Saccharomyces cerevisiae
by: Jin, J.
Published: (2011) -
Increasing the efficiency of antibody purification process by high throughput technology and intelligent design of experiment
by: Khan, Muazzam Ali
Published: (2018) -
Bioprocess intensification : production of bioethanol from Saccharomyces cerevisiae W303 in monolithic microreactor
by: Wan Md Zain, Wan Salwanis
Published: (2013)